Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of CAR T-Cell Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of CAR T-Cell Therapymarket, defines the market attractiveness level of CAR T-Cell Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of CAR T-Cell Therapy industry, describes the types of CAR T-Cell Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global CAR T-Cell Therapy market and the development prospects and opportunities of CAR T-Cell Therapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global CAR T-Cell Therapy market in Chapter 13.
By Player:
Mustang Bio (US)
Kite Pharma (US)
Autolus Therapeutics PLC (UK)
Cellectis (France)
Legend Biotech (US)
Pfizer, Inc (US)
CARsgen Therapeutics (China)
Novartis AG (Switzerland)
Juno Therapeutics (US)
Sorrento Therapeutics (US)
By Type:
Allogeneic
Autologous
By End-User:
Hospitals
Cancer Research Centers
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 CAR T-Cell Therapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 CAR T-Cell Therapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 CAR T-Cell Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 CAR T-Cell Therapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise CAR T-Cell Therapy Market Analysis and Outlook to 2022
-
7.1 Global CAR T-Cell Therapy Consumption (2017-2022)
-
7.2 United States CAR T-Cell Therapy Consumption (2017-2022)
-
7.3 Europe CAR T-Cell Therapy Consumption (2017-2022)
-
7.4 China CAR T-Cell Therapy Consumption (2017-2022)
-
7.5 Japan CAR T-Cell Therapy Consumption (2017-2022)
-
7.6 India CAR T-Cell Therapy Consumption (2017-2022)
-
7.7 South Korea CAR T-Cell Therapy Consumption (2017-2022)
8 Region and Country-wise CAR T-Cell Therapy Market Analysis and Outlook to 2028
-
8.1 Global CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
8.2 United States CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
8.3 Europe CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
8.4 China CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
8.5 Japan CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
8.6 India CAR T-Cell Therapy Consumption Forecast (2022-2028)
-
8.7 South Korea CAR T-Cell Therapy Consumption Forecast (2022-2028)
9 Global CAR T-Cell Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global CAR T-Cell Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Allogeneic Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Autologous Consumption and Growth Rate (2017-2022)
-
9.2 Global CAR T-Cell Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Research Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global CAR T-Cell Therapy Market Outlook by Types and Applications to 2028
-
10.1 Global CAR T-Cell Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Allogeneic Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Autologous Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global CAR T-Cell Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global CAR T-Cell Therapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global CAR T-Cell Therapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global CAR T-Cell Therapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 CAR T-Cell Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global CAR T-Cell Therapy Market Competitive Analysis
-
14.1 Mustang Bio (US)
-
14.1.1 Mustang Bio (US) Company Details
-
14.1.2 Mustang Bio (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Mustang Bio (US) CAR T-Cell Therapy Product and Service
-
14.2 Kite Pharma (US)
-
14.2.1 Kite Pharma (US) Company Details
-
14.2.2 Kite Pharma (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Kite Pharma (US) CAR T-Cell Therapy Product and Service
-
14.3 Autolus Therapeutics PLC (UK)
-
14.3.1 Autolus Therapeutics PLC (UK) Company Details
-
14.3.2 Autolus Therapeutics PLC (UK) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Autolus Therapeutics PLC (UK) CAR T-Cell Therapy Product and Service
-
14.4 Cellectis (France)
-
14.4.1 Cellectis (France) Company Details
-
14.4.2 Cellectis (France) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Cellectis (France) CAR T-Cell Therapy Product and Service
-
14.5 Legend Biotech (US)
-
14.5.1 Legend Biotech (US) Company Details
-
14.5.2 Legend Biotech (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Legend Biotech (US) CAR T-Cell Therapy Product and Service
-
14.6 Pfizer, Inc (US)
-
14.6.1 Pfizer, Inc (US) Company Details
-
14.6.2 Pfizer, Inc (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer, Inc (US) CAR T-Cell Therapy Product and Service
-
14.7 CARsgen Therapeutics (China)
-
14.7.1 CARsgen Therapeutics (China) Company Details
-
14.7.2 CARsgen Therapeutics (China) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 CARsgen Therapeutics (China) CAR T-Cell Therapy Product and Service
-
14.8 Novartis AG (Switzerland)
-
14.8.1 Novartis AG (Switzerland) Company Details
-
14.8.2 Novartis AG (Switzerland) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novartis AG (Switzerland) CAR T-Cell Therapy Product and Service
-
14.9 Juno Therapeutics (US)
-
14.9.1 Juno Therapeutics (US) Company Details
-
14.9.2 Juno Therapeutics (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Juno Therapeutics (US) CAR T-Cell Therapy Product and Service
-
14.10 Sorrento Therapeutics (US)
-
14.10.1 Sorrento Therapeutics (US) Company Details
-
14.10.2 Sorrento Therapeutics (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sorrento Therapeutics (US) CAR T-Cell Therapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of CAR T-Cell Therapy
-
Figure CAR T-Cell Therapy Picture
-
Table Global CAR T-Cell Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global CAR T-Cell Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global CAR T-Cell Therapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global CAR T-Cell Therapy Consumption by Country (2017-2022)
-
Figure United States CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure China CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure India CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea CAR T-Cell Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global CAR T-Cell Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea CAR T-Cell Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Allogeneic Consumption and Growth Rate (2017-2022)
-
Figure Global Autologous Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Research Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Allogeneic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autologous Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global CAR T-Cell Therapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global CAR T-Cell Therapy Export by Region (Top 5 Countries) (2017-2028)
-
Table Mustang Bio (US) (Foundation Year, Company Profile and etc.)
-
Table Mustang Bio (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mustang Bio (US) CAR T-Cell Therapy Product and Service
-
Table Kite Pharma (US) (Foundation Year, Company Profile and etc.)
-
Table Kite Pharma (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kite Pharma (US) CAR T-Cell Therapy Product and Service
-
Table Autolus Therapeutics PLC (UK) (Foundation Year, Company Profile and etc.)
-
Table Autolus Therapeutics PLC (UK) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Autolus Therapeutics PLC (UK) CAR T-Cell Therapy Product and Service
-
Table Cellectis (France) (Foundation Year, Company Profile and etc.)
-
Table Cellectis (France) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cellectis (France) CAR T-Cell Therapy Product and Service
-
Table Legend Biotech (US) (Foundation Year, Company Profile and etc.)
-
Table Legend Biotech (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Legend Biotech (US) CAR T-Cell Therapy Product and Service
-
Table Pfizer, Inc (US) (Foundation Year, Company Profile and etc.)
-
Table Pfizer, Inc (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer, Inc (US) CAR T-Cell Therapy Product and Service
-
Table CARsgen Therapeutics (China) (Foundation Year, Company Profile and etc.)
-
Table CARsgen Therapeutics (China) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table CARsgen Therapeutics (China) CAR T-Cell Therapy Product and Service
-
Table Novartis AG (Switzerland) (Foundation Year, Company Profile and etc.)
-
Table Novartis AG (Switzerland) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG (Switzerland) CAR T-Cell Therapy Product and Service
-
Table Juno Therapeutics (US) (Foundation Year, Company Profile and etc.)
-
Table Juno Therapeutics (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Juno Therapeutics (US) CAR T-Cell Therapy Product and Service
-
Table Sorrento Therapeutics (US) (Foundation Year, Company Profile and etc.)
-
Table Sorrento Therapeutics (US) CAR T-Cell Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sorrento Therapeutics (US) CAR T-Cell Therapy Product and Service
-
